To assess the relevance of CD47-SIRPα signaling in neuroblastoma, we first examined the gene expression levels of CD47 in this tumor type and compared it to the levels in the respective healthy tissue, being the adrenal gland in our case [44,45]. The gene discussed is CD47; the disease is neoplasm.